HEADER ADP-RIBOSYLATION 11-DEC-95 1AER TITLE DOMAIN III OF PSEUDOMONAS AERUGINOSA EXOTOXIN COMPLEXED TITLE 2 WITH BETA-TAD COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXOTOXIN A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: DOMAIN III OF PSEUDOMONAS TOXIN; COMPND 5 EC: 2.4.2.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PPED5-399 KEYWDS TOXIN, SIGNAL, ADP-RIBOSYLATION, TRANSFERASE, KEYWDS 2 GLYCOSYLTRANSFERASE, NAD EXPDTA X-RAY DIFFRACTION AUTHOR M.LI,F.DYDA,I.BENHAR,I.PASTAN,D.R.DAVIES REVDAT 3 24-FEB-09 1AER 1 VERSN REVDAT 2 01-APR-03 1AER 1 JRNL REVDAT 1 10-JUN-96 1AER 0 JRNL AUTH M.LI,F.DYDA,I.BENHAR,I.PASTAN,D.R.DAVIES JRNL TITL CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF JRNL TITL 2 PSEUDOMONAS EXOTOXIN A COMPLEXED WITH A JRNL TITL 3 NICOTINAMIDE ADENINE DINUCLEOTIDE ANALOG: JRNL TITL 4 IMPLICATIONS FOR THE ACTIVATION PROCESS AND FOR JRNL TITL 5 ADP RIBOSYLATION JRNL REF PROC.NATL.ACAD.SCI.USA V. 93 6902 1996 JRNL REFN ISSN 0027-8424 JRNL PMID 8692916 JRNL DOI 10.1073/PNAS.93.14.6902 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.LI,F.DYDA,I.BENHAR,I.PASTAN,D.R.DAVIES REMARK 1 TITL THE CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA REMARK 1 TITL 2 EXOTOXIN DOMAIN III WITH NICOTINAMIDE AND AMP: REMARK 1 TITL 3 CONFORMATIONAL DIFFERENCES WITH THE INTACT EXOTOXIN REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 92 9308 1995 REMARK 1 REFN ISSN 0027-8424 REMARK 1 REFERENCE 2 REMARK 1 AUTH V.S.ALLURED,R.J.COLLIER,S.F.CARROLL,D.B.MCKAY REMARK 1 TITL STRUCTURE OF EXOTOXIN A OF PSEUDOMONAS AERUGINOSA REMARK 1 TITL 2 AT 3.0-ANGSTROM RESOLUTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 83 1320 1986 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 21956 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3023 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 83 REMARK 3 SOLVENT ATOMS : 108 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 2.05 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.37 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.86 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1AER COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : APR-95 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22417 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.86500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.82000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.82000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 100.29750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.82000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.82000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.43250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.82000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.82000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 100.29750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.82000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.82000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 33.43250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 66.86500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 458 REMARK 465 SER A 459 REMARK 465 GLN A 460 REMARK 465 ASP A 461 REMARK 465 LEU A 462 REMARK 465 ASP A 463 REMARK 465 ALA B 399 REMARK 465 ALA B 489 REMARK 465 GLU B 546 REMARK 465 GLU B 547 REMARK 465 GLU B 548 REMARK 465 GLY B 549 REMARK 465 GLY B 550 REMARK 465 ALA B 601 REMARK 465 SER B 602 REMARK 465 GLN B 603 REMARK 465 PRO B 604 REMARK 465 GLY B 605 REMARK 465 LYS B 606 REMARK 465 PRO B 607 REMARK 465 PRO B 608 REMARK 465 ARG B 609 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 412 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 456 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 486 CG CD OE1 OE2 REMARK 470 GLU A 547 CG CD OE1 OE2 REMARK 470 GLU A 548 CG CD OE1 OE2 REMARK 470 LYS A 606 CG CD CE NZ REMARK 470 ARG B 456 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 484 CG OD1 OD2 REMARK 470 GLN B 485 CG CD OE1 NE2 REMARK 470 GLU B 486 CG CD OE1 OE2 REMARK 470 ARG B 490 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 522 CG CD OE1 OE2 REMARK 470 ARG B 576 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 599 CG OD1 OD2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 606 CB REMARK 480 ARG A 609 OXT REMARK 480 GLN B 460 CG CD OE1 NE2 REMARK 480 ARG B 494 C CB REMARK 480 ARG B 576 C O CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 452 55.69 -110.44 REMARK 500 TRP A 466 34.69 -95.80 REMARK 500 ASP A 488 -163.37 -68.39 REMARK 500 ARG A 538 -100.40 -108.92 REMARK 500 LEU A 539 54.53 -98.96 REMARK 500 ASN A 577 57.29 -152.27 REMARK 500 ALA B 482 -147.31 -162.87 REMARK 500 GLN B 485 78.41 -69.88 REMARK 500 ARG B 538 -106.88 -123.32 REMARK 500 LEU B 539 42.12 -85.09 REMARK 500 ASN B 577 -93.45 -113.11 REMARK 500 VAL B 578 82.84 92.96 REMARK 500 ASP B 581 88.38 -60.48 REMARK 500 SER B 595 31.31 -99.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 AMP B 701 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TIA B 700 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TAD A 700 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AMP B 701 REMARK 999 REMARK 999 SEQUENCE REMARK 999 REMARK 999 THE SEQUENCE IN THIS ENTRY IS FROM 400 TO 613 FROM THAT OF REMARK 999 THE COMPLETE TOXIN IN GENE BANK. THERE ARE TWO MONOMERS IN REMARK 999 THE ASYMMETRIC UNIT: MONOMER 1 FROM A 400 TO A 609 WITH REMARK 999 BETA-TAD NUMBERED 700. RESIDUES A 458 - A 463 AND A 610 - REMARK 999 A 613 ARE NOT DEFINED. MONOMER 2 IS FROM B 400 TO B 600 REMARK 999 WITH THIAZOLE RIBOSE NUMBERED B 700 AND AMP B 701. RESIDUE REMARK 999 NAME "TIA" IS GIVEN TO THIAZOLE RIBOSE. DBREF 1AER A 400 609 UNP P11439 TOXA_PSEAE 425 634 DBREF 1AER B 400 609 UNP P11439 TOXA_PSEAE 425 634 SEQRES 1 A 211 ALA PHE LEU GLY ASP GLY GLY ASP VAL SER PHE SER THR SEQRES 2 A 211 ARG GLY THR GLN ASN TRP THR VAL GLU ARG LEU LEU GLN SEQRES 3 A 211 ALA HIS ARG GLN LEU GLU GLU ARG GLY TYR VAL PHE VAL SEQRES 4 A 211 GLY TYR HIS GLY THR PHE LEU GLU ALA ALA GLN SER ILE SEQRES 5 A 211 VAL PHE GLY GLY VAL ARG ALA ARG SER GLN ASP LEU ASP SEQRES 6 A 211 ALA ILE TRP ARG GLY PHE TYR ILE ALA GLY ASP PRO ALA SEQRES 7 A 211 LEU ALA TYR GLY TYR ALA GLN ASP GLN GLU PRO ASP ALA SEQRES 8 A 211 ARG GLY ARG ILE ARG ASN GLY ALA LEU LEU ARG VAL TYR SEQRES 9 A 211 VAL PRO ARG SER SER LEU PRO GLY PHE TYR ARG THR SER SEQRES 10 A 211 LEU THR LEU ALA ALA PRO GLU ALA ALA GLY GLU VAL GLU SEQRES 11 A 211 ARG LEU ILE GLY HIS PRO LEU PRO LEU ARG LEU ASP ALA SEQRES 12 A 211 ILE THR GLY PRO GLU GLU GLU GLY GLY ARG LEU GLU THR SEQRES 13 A 211 ILE LEU GLY TRP PRO LEU ALA GLU ARG THR VAL VAL ILE SEQRES 14 A 211 PRO SER ALA ILE PRO THR ASP PRO ARG ASN VAL GLY GLY SEQRES 15 A 211 ASP LEU ASP PRO SER SER ILE PRO ASP LYS GLU GLN ALA SEQRES 16 A 211 ILE SER ALA LEU PRO ASP TYR ALA SER GLN PRO GLY LYS SEQRES 17 A 211 PRO PRO ARG SEQRES 1 B 211 ALA PHE LEU GLY ASP GLY GLY ASP VAL SER PHE SER THR SEQRES 2 B 211 ARG GLY THR GLN ASN TRP THR VAL GLU ARG LEU LEU GLN SEQRES 3 B 211 ALA HIS ARG GLN LEU GLU GLU ARG GLY TYR VAL PHE VAL SEQRES 4 B 211 GLY TYR HIS GLY THR PHE LEU GLU ALA ALA GLN SER ILE SEQRES 5 B 211 VAL PHE GLY GLY VAL ARG ALA ARG SER GLN ASP LEU ASP SEQRES 6 B 211 ALA ILE TRP ARG GLY PHE TYR ILE ALA GLY ASP PRO ALA SEQRES 7 B 211 LEU ALA TYR GLY TYR ALA GLN ASP GLN GLU PRO ASP ALA SEQRES 8 B 211 ARG GLY ARG ILE ARG ASN GLY ALA LEU LEU ARG VAL TYR SEQRES 9 B 211 VAL PRO ARG SER SER LEU PRO GLY PHE TYR ARG THR SER SEQRES 10 B 211 LEU THR LEU ALA ALA PRO GLU ALA ALA GLY GLU VAL GLU SEQRES 11 B 211 ARG LEU ILE GLY HIS PRO LEU PRO LEU ARG LEU ASP ALA SEQRES 12 B 211 ILE THR GLY PRO GLU GLU GLU GLY GLY ARG LEU GLU THR SEQRES 13 B 211 ILE LEU GLY TRP PRO LEU ALA GLU ARG THR VAL VAL ILE SEQRES 14 B 211 PRO SER ALA ILE PRO THR ASP PRO ARG ASN VAL GLY GLY SEQRES 15 B 211 ASP LEU ASP PRO SER SER ILE PRO ASP LYS GLU GLN ALA SEQRES 16 B 211 ILE SER ALA LEU PRO ASP TYR ALA SER GLN PRO GLY LYS SEQRES 17 B 211 PRO PRO ARG HET TIA B 700 16 HET TAD A 700 43 HET AMP B 701 23 HETNAM TIA 2-(1,5-DIDEOXYRIBOSE)-4-AMIDO-THIAZOLE HETNAM TAD BETA-METHYLENE-THIAZOLE-4-CARBOXYAMIDE-ADENINE HETNAM 2 TAD DINUCLEOTIDE HETNAM AMP ADENOSINE MONOPHOSPHATE FORMUL 3 TIA C9 H12 N2 O4 S FORMUL 4 TAD C20 H27 N7 O13 P2 S FORMUL 5 AMP C10 H14 N5 O7 P FORMUL 6 HOH *108(H2 O) HELIX 1 1 VAL A 419 GLU A 431 1 13 HELIX 2 2 LEU A 444 VAL A 451 1 8 HELIX 3 3 PRO A 475 TYR A 481 1 7 HELIX 4 4 ARG A 505 GLY A 510 5 6 HELIX 5 5 PRO A 521 ILE A 531 5 11 HELIX 6 6 TRP A 558 ARG A 563 1 6 HELIX 7 7 PRO A 584 SER A 586 5 3 HELIX 8 8 ASP A 589 ILE A 594 1 6 HELIX 9 9 VAL B 419 ARG B 432 1 14 HELIX 10 10 LEU B 444 PHE B 452 1 9 HELIX 11 11 PRO B 475 GLY B 480 1 6 HELIX 12 12 ARG B 505 GLY B 510 5 6 HELIX 13 13 PRO B 521 ILE B 531 1 11 HELIX 14 14 TRP B 558 ARG B 563 1 6 HELIX 15 15 PRO B 584 SER B 586 5 3 HELIX 16 16 ASP B 589 ILE B 594 1 6 SHEET 1 A 4 PHE A 469 ILE A 471 0 SHEET 2 A 4 LEU A 552 LEU A 556 -1 N LEU A 556 O PHE A 469 SHEET 3 A 4 ALA A 541 PRO A 545 -1 N GLY A 544 O GLU A 553 SHEET 4 A 4 PHE A 511 ARG A 513 1 N TYR A 512 O ALA A 541 SHEET 1 B 3 VAL A 565 PRO A 568 0 SHEET 2 B 3 ALA A 497 PRO A 504 -1 N TYR A 502 O VAL A 565 SHEET 3 B 3 TYR A 434 THR A 442 -1 N THR A 442 O ALA A 497 SHEET 1 C 4 PHE B 469 ILE B 471 0 SHEET 2 C 4 GLU B 553 LEU B 556 -1 N LEU B 556 O PHE B 469 SHEET 3 C 4 ALA B 541 GLY B 544 -1 N GLY B 544 O GLU B 553 SHEET 4 C 4 PHE B 511 ARG B 513 1 N TYR B 512 O ALA B 541 SHEET 1 D 3 VAL B 565 PRO B 568 0 SHEET 2 D 3 ALA B 497 PRO B 504 -1 N TYR B 502 O VAL B 565 SHEET 3 D 3 TYR B 434 THR B 442 -1 N THR B 442 O ALA B 497 LINK O2D TAD A 700 OE1 GLU A 553 1555 1555 2.39 CISPEP 1 LEU A 535 PRO A 536 0 -0.40 CISPEP 2 LEU B 535 PRO B 536 0 0.00 SITE 1 AC1 6 HIS B 440 GLY B 441 TYR B 470 ALA B 478 SITE 2 AC1 6 TYR B 481 GLU B 553 SITE 1 AC2 16 HOH A 56 HOH A 80 HOH A 104 HIS A 440 SITE 2 AC2 16 GLY A 441 THR A 442 PHE A 443 ALA A 446 SITE 3 AC2 16 SER A 449 ILE A 450 GLY A 454 VAL A 455 SITE 4 AC2 16 ARG A 456 TYR A 470 TYR A 481 GLU A 553 SITE 1 AC3 11 ARG A 609 HIS B 440 THR B 442 ALA B 446 SITE 2 AC3 11 SER B 449 ILE B 450 GLY B 454 VAL B 455 SITE 3 AC3 11 ARG B 456 ARG B 458 PHE B 469 CRYST1 87.640 87.640 133.730 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011410 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011410 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007478 0.00000